I appreciate the letter written by my friend and colleague, Dr. Stotland. I share her concerns about women’s place in society and the burdens women must shoulder. Even in 2012, we continue to fight for pay equality and to live in homes that are free of interpersonal violence. As chair of the subcommittee that evaluated whether the category premenstrual dysphoric disorder (PMDD) should be placed in DSM-5 or remain in the appendix, my charge was to work with experts and evaluate the scientific evidence for such a change. Theoretical, political, and sociological arguments aside, our evaluation found ample scientific evidence, grounded in biological, epidemiological, and treatment results, for the movement of the category to the manual. Much of this evidence was outlined in the May American Journal of Psychiatry (AJP) and written by our sub-work group.